| (Values in U.S. Thousands) | Mar, 2018 | Dec, 2017 | Sep, 2017 | Jun, 2017 | Mar, 2017 |
| Sales | -9,999,000 | 29,900 | 28,950 | 28,440 | 30,280 |
| Sales Growth | -33,541.47% | +3.28% | +1.79% | -6.08% | +6.73% |
| Net Income | -9,999,000 | 6,520 | 4,150 | 5,750 | 6,520 |
| Net Income Growth | -153,458.90% | +57.11% | -27.83% | -11.81% | +7.59% |
Natl Research Cl B (NRCIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
National Research Corporation is a leading provider of ongoing survey-based performance measurement, analysis and tracking services to the healthcare industry. The company addresses the growing need of healthcare providers and payers to measure the care outcomes, specifically satisfaction and health status, of their patients and/or members. The company's primary types of information services are renewable performance tracking services, custom research and a renewable syndicated service.
Fiscal Year End Date: 12/31